Etzer Darout
Stock Analyst at Barclays
(4.97)
# 82
Out of 4,712 analysts
517
Total ratings
63.4%
Success rate
33.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Etzer Darout
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KURA Kura Oncology | Maintained: Buy | $28 | $12.09 | +131.60% | 15 | Sep 10, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | $270 → $271 | $241.31 | +12.30% | 8 | Sep 10, 2026 | |
| ONC BeOne Medicines AG | Maintained: Buy | $407 → $415 | $351.00 | +18.23% | 10 | Sep 10, 2026 | |
| TRAX First Tracks Biotherapeutics | Reiterated: Buy | $65 | $39.57 | +64.27% | 6 | Sep 3, 2026 | |
| PTGX Protagonist Therapeutics | Reiterated: Buy | $153 → $180 | $145.09 | +24.06% | 12 | Aug 31, 2026 | |
| TVRD Tvardi Therapeutics | Reiterated: Sell | $3 | $1.85 | +62.16% | 10 | Aug 20, 2026 | |
| ELVN Enliven Therapeutics | Initiated Coverage: Buy | $78 | $57.45 | +35.77% | 1 | Aug 18, 2026 | |
| MGNX MacroGenics | Reiterated: Buy | $6 | $4.11 | +45.99% | 34 | Aug 14, 2026 | |
| MNPR Monopar Therapeutics | Reiterated: Buy | $125 → $128 | $112.38 | +13.90% | 9 | Aug 13, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Hold | $18 | $17.54 | +2.62% | 12 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.44 | +103.49% | 30 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $78 | $19.91 | +291.76% | 11 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 | $91.50 | +74.86% | 8 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $53 | $38.78 | +36.67% | 8 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $13.33 | +110.05% | 7 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $3.54 | +351.98% | 31 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $13 | $8.43 | +54.21% | 12 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $14 | $19.33 | -27.57% | 7 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $30 | $18.66 | +60.77% | 7 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $54.62 | +0.70% | 20 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $49 | $58.33 | -16.00% | 34 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $10.81 | +177.52% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $24.94 | +8.26% | 32 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $8.76 | +128.31% | 36 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $19.84 | +86.49% | 15 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $55.70 | +34.65% | 12 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $134 → $139 | $126.01 | +10.31% | 17 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $148 | $119.46 | +23.89% | 11 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $119 | $115.43 | +3.09% | 5 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $4.45 | n/a | 1 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 → $143 | $98.13 | n/a | 10 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.99 | n/a | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.44 | n/a | 16 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.67 | n/a | 7 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $33.04 | n/a | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $26.26 | n/a | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $137.48 | n/a | 7 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.14 | n/a | 4 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $63 | $0.701 | n/a | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $37 | $98.30 | n/a | 2 | Sep 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $0.00001 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $60 | $0.54 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $25 | $6.59 | n/a | 2 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $3.83 | n/a | 2 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €22.39 → €25.83 | €3.80 | n/a | 2 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $162 | $258.00 | n/a | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $27.15 | n/a | 4 | Jul 14, 2020 |
Kura Oncology
Sep 10, 2026
Maintained: Buy
Price Target: $28
Current: $12.09
Upside: +131.60%
Jazz Pharmaceuticals
Sep 10, 2026
Maintained: Buy
Price Target: $270 → $271
Current: $241.31
Upside: +12.30%
BeOne Medicines AG
Sep 10, 2026
Maintained: Buy
Price Target: $407 → $415
Current: $351.00
Upside: +18.23%
First Tracks Biotherapeutics
Sep 3, 2026
Reiterated: Buy
Price Target: $65
Current: $39.57
Upside: +64.27%
Protagonist Therapeutics
Aug 31, 2026
Reiterated: Buy
Price Target: $153 → $180
Current: $145.09
Upside: +24.06%
Tvardi Therapeutics
Aug 20, 2026
Reiterated: Sell
Price Target: $3
Current: $1.85
Upside: +62.16%
Enliven Therapeutics
Aug 18, 2026
Initiated Coverage: Buy
Price Target: $78
Current: $57.45
Upside: +35.77%
MacroGenics
Aug 14, 2026
Reiterated: Buy
Price Target: $6
Current: $4.11
Upside: +45.99%
Monopar Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $125 → $128
Current: $112.38
Upside: +13.90%
Summit Therapeutics
Aug 13, 2026
Reiterated: Hold
Price Target: $18
Current: $17.54
Upside: +2.62%
Aug 12, 2026
Reiterated: Buy
Price Target: $7
Current: $3.44
Upside: +103.49%
Aug 11, 2026
Reiterated: Buy
Price Target: $80 → $78
Current: $19.91
Upside: +291.76%
Aug 11, 2026
Reiterated: Buy
Price Target: $160
Current: $91.50
Upside: +74.86%
Aug 7, 2026
Reiterated: Buy
Price Target: $48 → $53
Current: $38.78
Upside: +36.67%
Aug 7, 2026
Reiterated: Buy
Price Target: $28
Current: $13.33
Upside: +110.05%
Aug 7, 2026
Reiterated: Buy
Price Target: $16
Current: $3.54
Upside: +351.98%
Aug 7, 2026
Reiterated: Buy
Price Target: $11 → $13
Current: $8.43
Upside: +54.21%
Aug 7, 2026
Reiterated: Sell
Price Target: $14
Current: $19.33
Upside: -27.57%
Aug 7, 2026
Reiterated: Buy
Price Target: $27 → $30
Current: $18.66
Upside: +60.77%
Aug 7, 2026
Reiterated: Buy
Price Target: $55
Current: $54.62
Upside: +0.70%
Aug 6, 2026
Reiterated: Hold
Price Target: $49
Current: $58.33
Upside: -16.00%
Aug 6, 2026
Reiterated: Buy
Price Target: $30
Current: $10.81
Upside: +177.52%
Aug 6, 2026
Reiterated: Buy
Price Target: $27
Current: $24.94
Upside: +8.26%
Aug 5, 2026
Reiterated: Buy
Price Target: $20
Current: $8.76
Upside: +128.31%
Aug 5, 2026
Reiterated: Buy
Price Target: $37
Current: $19.84
Upside: +86.49%
Jul 31, 2026
Reiterated: Buy
Price Target: $75
Current: $55.70
Upside: +34.65%
Jul 28, 2026
Reiterated: Buy
Price Target: $134 → $139
Current: $126.01
Upside: +10.31%
Jun 30, 2026
Reiterated: Buy
Price Target: $148
Current: $119.46
Upside: +23.89%
Dec 8, 2025
Reiterated: Buy
Price Target: $70 → $119
Current: $115.43
Upside: +3.09%
Apr 4, 2025
Reiterated: Buy
Price Target: $9
Current: $4.45
Upside: n/a
Mar 11, 2025
Reiterated: Buy
Price Target: $130 → $143
Current: $98.13
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $1.99
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $2.44
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $4.67
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $33.04
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $26.26
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $137.48
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $11.14
Upside: n/a
Feb 27, 2025
Initiated Coverage: Buy
Price Target: $63
Current: $0.701
Upside: n/a
Sep 13, 2021
Reiterated: Buy
Price Target: $38 → $37
Current: $98.30
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $7
Current: $0.00001
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $60
Current: $0.54
Upside: n/a
Mar 17, 2021
Reiterated: Buy
Price Target: $16 → $25
Current: $6.59
Upside: n/a
Mar 11, 2021
Reiterated: Buy
Price Target: $50 → $48
Current: $3.83
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: €22.39 → €25.83
Current: €3.80
Upside: n/a
Feb 22, 2021
Downgraded: Hold
Price Target: $162
Current: $258.00
Upside: n/a
Jul 14, 2020
Reiterated: Buy
Price Target: $48
Current: $27.15
Upside: n/a